These data indicate that rs538321148 and rs1014509103 polymorphisms may act as potential susceptibility factors for cancer risk, and the possibility of the genetic SNPs in ADAMTS4 influencing HCC risk should therefore not be ignored. This evidence concerns the gene ADAMTS4 and hepatocellular carcinoma.